Haisco Pharmaceutical Group's latest marketcap:
As of 08/31/2025, Haisco Pharmaceutical Group's market capitalization has reached $8.63 B. According to our data, Haisco Pharmaceutical Group is the 2280th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8.63 B |
| Revenue (ttm) | 565.9 M |
| Net Income (ttm) | 50.42 M |
| Shares Out | 1.11 B |
| EPS (ttm) | 0.05 |
| Forward PE | 117.17 |
| Ex-Dividend Date | 05/15/2025 |
| Earnings Date | 08/23/2025 |
Haisco Pharmaceutical Group's yearly market capitalization.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/31/2025 | ¥61.52 B | $8.63 B | 66.89% | 2280 |
| 12/31/2024 | ¥36.88 B | $5.05 B | 44.38% | 2971 |
| 12/29/2023 | ¥25.55 B | $3.6 B | 7.81% | 3712 |
| 12/30/2022 | ¥23.7 B | $3.43 B | 8.96% | 3644 |
| 12/31/2021 | ¥21.75 B | $3.42 B | 16.68% | 4329 |
| 12/31/2020 | ¥18.64 B | $2.86 B | -14.41% | 4278 |
| 12/31/2019 | ¥21.78 B | $3.13 B | 71.24% | 3386 |
| 12/28/2018 | ¥12.72 B | $1.85 B | 4.57% | 4217 |
| 12/29/2017 | ¥12.16 B | $1.87 B | -27.6% | 4785 |
| 12/30/2016 | ¥16.8 B | $2.42 B | -28.96% | 3450 |
Company Profile
About Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company based in China, specializing in the research, development, manufacturing, and sale of a diverse range of medical products.
Product Portfolio
The company offers a variety of pharmaceutical solutions, including:
- Cycloporol
- Dolasetron mesylate
- Polyene phosphatidylcholine
- Compound amino acid
- Methylprednisolone sodium injections
- Flupenthixol melitracen tablets
Therapeutic Applications
Haisco's products cater to multiple medical fields, such as:
- Anesthesia
- Parenteral nutrition
- Tumor antiemetic
- Liver and gallbladder digestion
- Antibiotics
- Cardiovascular and cerebrovascular treatments
Company Background
Originally established as Xizang Haisco Pharmaceutical Group Co., Ltd., the company rebranded to its current name in March 2016. Founded in 2005, Haisco is headquartered in Shannan, China.
Frequently Asked Questions
-
What is Haisco Pharmaceutical Group's (SHE-002653) current market cap?As of 08/31/2025, Haisco Pharmaceutical Group (including the parent company, if applicable) has an estimated market capitalization of $8.63 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Haisco Pharmaceutical Group (SHE-002653) rank globally by market cap?Haisco Pharmaceutical Group global market capitalization ranking is approximately 2280 as of 08/31/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.